Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer

SIMPLE SUMMARY: Immunotherapy for non-small cell lung cancer (NSCLC) is a clinical reality with impressive efficacy for some patients. However, less than half of them will benefit from this therapeutic regime, and finding indicators of response is necessary for selecting the patients likely to respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Otegui, Nerea, Houry, Maeva, Arozarena, Imanol, Serrano, Diego, Redin, Esther, Exposito, Francisco, Leon, Sergio, Valencia, Karmele, Montuenga, Luis, Calvo, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295869/
https://www.ncbi.nlm.nih.gov/pubmed/37370686
http://dx.doi.org/10.3390/cancers15123076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295869/
https://www.ncbi.nlm.nih.gov/pubmed/37370686
http://dx.doi.org/10.3390/cancers15123076

Ejemplares similares